Warning letter to Australian API manufac
USFDA Warning letter to Australian API manufacturer cites basic laboratory compliance issues – Inadequate OOS
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
